Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. It's only ...

After a surgical first, a Swiss neurotech company is getting closer to treating severe neurological disorders with its unique brain interface designed as a safe alternative to existing brain implants.

Neurosoft Bioelectronics has become the inaugural partner under an agreement with Science Corporation that gives the brain computer interface (BCI) technology company the ability to develop products ...

Deal Joins Science’s World-Class BCI Tools with Neurosoft’s Leading Neural Data Platform Science Ecosystem partners enter into multiyear agreements to develop brain-computer interface (BCI) products ...

As the regional winner, Neurosoft Bioelectronics advances to the Startup World Cup Grand Finale, to be held in San Francisco on November 2026, where they will compete for the ultimate prize: a ...

Neurosoft (NRST) has delivered a 15.870% change over the past year, with a 52-week range between 0.460 and 0.930. What Is the Average Daily Trading Volume of Neurosoft (NRST)? The average daily ...

* As a consequence the total share capital of Neurosoft will amount to 8,954,607.90 euros divided into 25,584,594 shares, that comes from the sum of the 25,000,000 Neurosoft ordinary shares and the ...

Within Elon Musk’s suite of corporations sits Neuralink, which aims to create a brain-computer interface through surgically implanted brain chips. Though evidence, details and timelines remain scarce, ...

The Neurosoft EPS (TTM) is 0.06.

ALAMEDA, Calif. & GENEVA--(BUSINESS WIRE)--Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural ...